G Medical Innovations Holdings Ltd. (GMVD)

NASDAQ: GMVD · IEX Real-Time Price · USD
0.403
+0.004 (1.00%)
Aug 19, 2022 3:35 PM EDT - Market open

Income Statement (Annual)

Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year 202120202019
Revenue
5.064.95.53
Revenue Growth (YoY)
3.22%-11.33%-
Cost of Revenue
3.564.235.75
Gross Profit
1.50.67-0.22
Selling, General & Admin
11.0911.6510
Research & Development
1.681.322.55
Operating Expenses
12.7712.9712.56
Operating Income
-11.27-12.3-12.78
Interest Expense / Income
3.620.413.59
Other Expense / Income
-29.65-25.22-30.52
Pretax Income
14.7612.5214.16
Income Tax
-0-0.02-0.86
Net Income
14.7612.5415.01
Net Income Common
14.7612.5415.01
Net Income Growth
17.72%-16.50%-
Shares Outstanding (Basic)
1174
Shares Outstanding (Diluted)
1174
Shares Change
54.45%70.77%-
EPS (Basic)
-1.30-1.70-3.49
EPS (Diluted)
-1.30-1.70-3.49
Free Cash Flow Per Share
-1.05-0.70-1.56
Gross Margin
29.70%13.60%-4.00%
Operating Margin
-222.80%-251.00%-231.30%
Profit Margin
291.80%255.80%271.70%
Free Cash Flow Margin
-236.80%-105.20%-121.70%
Effective Tax Rate
-0.02%-0.14%-6.05%
EBITDA
19.7414.3420.61
EBITDA Margin
390.30%292.70%373.00%
Depreciation & Amortization
1.361.422.87
EBIT
18.3812.9217.74
EBIT Margin
363.30%263.80%321.10%
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).